Most therapeutic research remains centered around experimental models of disease in rodents with limited work in the larger species, arguably narrowing the utility of these findings in horses on a clinical level
Weight loss medications, when covered, often fall into higher tiers, which typically result in higher out-of-pocket costs for members
The next #frontier may be metabolic health, where inflammation, insulin sensitivity, appetite regulation, mitochondrial function, and healthy aging all connect through the endocannabinoid system
Additionally, certain medical conditions (thyroid dysfunction, polycystic ovary syndrome, chronic inflammation) and medications (corticosteroids, antipsychotics) can interfere with weight loss progress independent of the GLP-1 compound itself